25 XP   0   0   10

Sinco Pharms Hldg Ltd
Buy, Hold or Sell?

Let's analyse Sinco Pharms Hldg Ltd together

PenkeI guess you are interested in Sinco Pharms Hldg Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Sinco Pharms Hldg Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Sinco Pharms Hldg Ltd

I send you an email if I find something interesting about Sinco Pharms Hldg Ltd.

Quick analysis of Sinco Pharms Hldg Ltd (30 sec.)










What can you expect buying and holding a share of Sinco Pharms Hldg Ltd? (30 sec.)

How much money do you get?

How much money do you get?
HK$0.00
When do you have the money?
1 year
How often do you get paid?
28.6%

What is your share worth?

Current worth
HK$0.32
Expected worth in 1 year
HK$0.33
How sure are you?
57.1%

+ What do you gain per year?

Total Gains per Share
HK$0.02
Return On Investment
9.6%

For what price can you sell your share?

Current Price per Share
HK$0.25
Expected price per share
HK$0.221 - HK$0.295
How sure are you?
50%

1. Valuation of Sinco Pharms Hldg Ltd (5 min.)




Live pricePrice per Share (EOD)

HK$0.25

2. Growth of Sinco Pharms Hldg Ltd (5 min.)




Is Sinco Pharms Hldg Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$83.4m$54.6m$28.3m34.2%

How much money is Sinco Pharms Hldg Ltd making?

Current yearPrevious yearGrowGrow %
Making money$1.4m$6.2m-$4.8m-348.6%
Net Profit Margin0.6%2.6%--

How much money comes from the company's main activities?

3. Financial Health of Sinco Pharms Hldg Ltd (5 min.)




4. Comparing to competitors in the Medical Distribution industry (5 min.)




  Industry Rankings (Medical Distribution)  

What can you expect buying and holding a share of Sinco Pharms Hldg Ltd? (5 min.)

Welcome investor! Sinco Pharms Hldg Ltd's management wants to use your money to grow the business. In return you get a share of Sinco Pharms Hldg Ltd.

What can you expect buying and holding a share of Sinco Pharms Hldg Ltd?

First you should know what it really means to hold a share of Sinco Pharms Hldg Ltd. And how you can make/lose money.

Speculation

The Price per Share of Sinco Pharms Hldg Ltd is HK$0.25. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Sinco Pharms Hldg Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Sinco Pharms Hldg Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is HK$0.32. Based on the TTM, the Book Value Change Per Share is HK$0.00 per quarter. Based on the YOY, the Book Value Change Per Share is HK$0.05 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is HK$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Sinco Pharms Hldg Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 HK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per Share
Usd Eps0.000.3%0.000.3%0.000.8%0.000.2%0.000.0%
Usd Book Value Change Per Share0.000.0%0.000.1%0.012.4%0.000.5%0.000.6%
Usd Dividend Per Share0.000.2%0.000.2%0.000.0%0.000.1%0.000.0%
Usd Total Gains Per Share0.000.3%0.000.3%0.012.4%0.000.6%0.000.6%
Usd Price Per Share0.04-0.04-0.20-0.08-0.06-
Price to Earnings Ratio13.93-14.41-23.68-16.11-10.64-
Price-to-Total Gains Ratio51.80-53.99-19.24-34.67-14.41-
Price to Book Ratio0.90-0.94-7.52-9.94-7.28-
Price-to-Total Gains Ratio51.80-53.99-19.24-34.67-14.41-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.031925
Number of shares31323
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (31323 shares)24.0343.28
Gains per Year (31323 shares)96.13173.11
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
177198616157163
21543818232314336
32315827849471509
43087737465628682
53859647081785855
6462115566979411028
753913466211310981201
861615375813012551374
969317385414614121547
1077019295016215691720

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%18.01.00.094.7%23.05.00.082.1%23.05.00.082.1%
Book Value Change Per Share2.00.02.050.0%6.00.06.050.0%9.01.09.047.4%14.05.09.050.0%14.05.09.050.0%
Dividend per Share4.00.00.0100.0%4.00.08.033.3%4.00.015.021.1%8.00.020.028.6%8.00.020.028.6%
Total Gains per Share4.00.00.0100.0%8.00.04.066.7%11.01.07.057.9%16.05.07.057.1%16.05.07.057.1%

Fundamentals of Sinco Pharms Hldg Ltd

About Sinco Pharms Hldg Ltd

Sinco Pharmaceuticals Holdings Limited, an investment holding company, provides marketing, promotion, and channel management services for imported pharmaceutical products and medical devices in China. The company offers Octapharma, a human albumin solution for use in premature infants; Axetine, which is used for the treatment of bacterial infections, including respiratory infections, urinary tract infections, soft tissue infections, gynecological and obstetrical infections, gonorrhea, and other infections, as well as for the prevention of post-surgery infections; and Medocef that is used for the treatment of bacterial infections, such as the infections of the lower respiratory tract comprising pneumonia, urinary tract, bile duct, peritoneum, skin, soft tissue, pelvic area, and sepsis. It also provides Esafosfina, which is used for treating hypophosphatemia and chronic diseases, which include alcohol intoxication, malnutrition, and hypophosphatemic respiratory failure; Taurolite, a third generation oral cholic acid drug that is used for the treatment of gallstone diseases; and Tamifil injection for the treatment of metastatic prostate cancer, true precocious puberty, and endometriosis. In addition, the company is involved in the research, development, and sale of pharmaceutical products; provision of warehouse facilities for pharmaceutical products; research and manufacturing of aesthetic medicine; international trade activities; consultation services for medical and biological technology; and medical beauty services. The company was founded in 2011 and is headquartered in Chengdu, the People's Republic of China. Sinco Pharmaceuticals Holdings Limited is a subsidiary of Risun Investments Limited.

Fundamental data was last updated by Penke on 2024-04-18 17:28:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is not making a profit/loss.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating inefficient.
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is underpriced.

1.1. Profitability of Sinco Pharms Hldg Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Sinco Pharms Hldg Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Sinco Pharms Hldg Ltd to the Medical Distribution industry mean.
  • A Net Profit Margin of 1.8% means that $0.02 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Sinco Pharms Hldg Ltd:

  • The MRQ is 1.8%. The company is making a profit. +1
  • The TTM is 0.6%. The company is not making a profit/loss.
Trends
Current periodCompared to+/- 
MRQ1.8%TTM0.6%+1.2%
TTM0.6%YOY2.6%-2.0%
TTM0.6%5Y2.1%-1.5%
5Y2.1%10Y-1.4%+3.6%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8%2.0%-0.2%
TTM0.6%2.1%-1.5%
YOY2.6%2.5%+0.1%
5Y2.1%2.2%-0.1%
10Y-1.4%2.1%-3.5%
1.1.2. Return on Assets

Shows how efficient Sinco Pharms Hldg Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Sinco Pharms Hldg Ltd to the Medical Distribution industry mean.
  • 1.2% Return on Assets means that Sinco Pharms Hldg Ltd generated $0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Sinco Pharms Hldg Ltd:

  • The MRQ is 1.2%. Using its assets, the company is less efficient in making profit.
  • The TTM is 0.7%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.2%TTM0.7%+0.5%
TTM0.7%YOY3.5%-2.8%
TTM0.7%5Y2.7%-2.0%
5Y2.7%10Y1.2%+1.4%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2%0.9%+0.3%
TTM0.7%0.9%-0.2%
YOY3.5%1.2%+2.3%
5Y2.7%1.0%+1.7%
10Y1.2%1.1%+0.1%
1.1.3. Return on Equity

Shows how efficient Sinco Pharms Hldg Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Sinco Pharms Hldg Ltd to the Medical Distribution industry mean.
  • 3.2% Return on Equity means Sinco Pharms Hldg Ltd generated $0.03 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Sinco Pharms Hldg Ltd:

  • The MRQ is 3.2%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 1.7%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ3.2%TTM1.7%+1.6%
TTM1.7%YOY11.8%-10.1%
TTM1.7%5Y19.4%-17.7%
5Y19.4%10Y13.1%+6.3%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ3.2%2.4%+0.8%
TTM1.7%2.4%-0.7%
YOY11.8%2.4%+9.4%
5Y19.4%2.4%+17.0%
10Y13.1%2.9%+10.2%

1.2. Operating Efficiency of Sinco Pharms Hldg Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Sinco Pharms Hldg Ltd is operating .

  • Measures how much profit Sinco Pharms Hldg Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Sinco Pharms Hldg Ltd to the Medical Distribution industry mean.
  • An Operating Margin of 2.6% means the company generated $0.03  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Sinco Pharms Hldg Ltd:

  • The MRQ is 2.6%. The company is operating less efficient.
  • The TTM is 0.6%. The company is operating inefficient. -1
Trends
Current periodCompared to+/- 
MRQ2.6%TTM0.6%+1.9%
TTM0.6%YOY1.8%-1.2%
TTM0.6%5Y2.1%-1.5%
5Y2.1%10Y1.5%+0.6%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ2.6%3.3%-0.7%
TTM0.6%2.6%-2.0%
YOY1.8%3.4%-1.6%
5Y2.1%3.4%-1.3%
10Y1.5%3.1%-1.6%
1.2.2. Operating Ratio

Measures how efficient Sinco Pharms Hldg Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Distribution industry mean).
  • An Operation Ratio of 0.86 means that the operating costs are $0.86 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Sinco Pharms Hldg Ltd:

  • The MRQ is 0.860. The company is less efficient in keeping operating costs low.
  • The TTM is 0.440. The company is very efficient in keeping operating costs low. +2
Trends
Current periodCompared to+/- 
MRQ0.860TTM0.440+0.420
TTM0.440YOY0.413+0.027
TTM0.4405Y0.535-0.094
5Y0.53510Y0.782-0.248
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8601.618-0.758
TTM0.4401.515-1.075
YOY0.4131.422-1.009
5Y0.5351.246-0.711
10Y0.7821.155-0.373

1.3. Liquidity of Sinco Pharms Hldg Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Sinco Pharms Hldg Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Distribution industry mean).
  • A Current Ratio of 1.18 means the company has $1.18 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Sinco Pharms Hldg Ltd:

  • The MRQ is 1.183. The company is just able to pay all its short-term debts.
  • The TTM is 1.235. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.183TTM1.235-0.052
TTM1.235YOY1.337-0.102
TTM1.2355Y1.040+0.195
5Y1.04010Y0.975+0.066
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1831.374-0.191
TTM1.2351.398-0.163
YOY1.3371.424-0.087
5Y1.0401.401-0.361
10Y0.9751.350-0.375
1.3.2. Quick Ratio

Measures if Sinco Pharms Hldg Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Sinco Pharms Hldg Ltd to the Medical Distribution industry mean.
  • A Quick Ratio of 0.86 means the company can pay off $0.86 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Sinco Pharms Hldg Ltd:

  • The MRQ is 0.856. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.649. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.856TTM0.649+0.207
TTM0.649YOY0.551+0.098
TTM0.6495Y0.475+0.174
5Y0.47510Y0.433+0.042
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8560.738+0.118
TTM0.6490.751-0.102
YOY0.5510.807-0.256
5Y0.4750.788-0.313
10Y0.4330.855-0.422

1.4. Solvency of Sinco Pharms Hldg Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Sinco Pharms Hldg Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Sinco Pharms Hldg Ltd to Medical Distribution industry mean.
  • A Debt to Asset Ratio of 0.63 means that Sinco Pharms Hldg Ltd assets are financed with 63.1% credit (debt) and the remaining percentage (100% - 63.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Sinco Pharms Hldg Ltd:

  • The MRQ is 0.631. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.603. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.631TTM0.603+0.028
TTM0.603YOY0.701-0.098
TTM0.6035Y0.796-0.193
5Y0.79610Y0.739+0.057
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6310.614+0.017
TTM0.6030.608-0.005
YOY0.7010.600+0.101
5Y0.7960.595+0.201
10Y0.7390.594+0.145
1.4.2. Debt to Equity Ratio

Measures if Sinco Pharms Hldg Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Sinco Pharms Hldg Ltd to the Medical Distribution industry mean.
  • A Debt to Equity ratio of 171.2% means that company has $1.71 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Sinco Pharms Hldg Ltd:

  • The MRQ is 1.712. The company is just able to pay all its debts with equity.
  • The TTM is 1.530. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.712TTM1.530+0.183
TTM1.530YOY2.480-0.950
TTM1.5305Y7.709-6.179
5Y7.70910Y5.982+1.727
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7121.558+0.154
TTM1.5301.630-0.100
YOY2.4801.697+0.783
5Y7.7091.704+6.005
10Y5.9821.760+4.222

2. Market Valuation of Sinco Pharms Hldg Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Sinco Pharms Hldg Ltd generates.

  • Above 15 is considered overpriced but always compare Sinco Pharms Hldg Ltd to the Medical Distribution industry mean.
  • A PE ratio of 13.93 means the investor is paying $13.93 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Sinco Pharms Hldg Ltd:

  • The EOD is 12.010. Based on the earnings, the company is underpriced. +1
  • The MRQ is 13.931. Based on the earnings, the company is underpriced. +1
  • The TTM is 14.412. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD12.010MRQ13.931-1.922
MRQ13.931TTM14.412-0.480
TTM14.412YOY23.681-9.269
TTM14.4125Y16.109-1.697
5Y16.10910Y10.639+5.470
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD12.01012.686-0.676
MRQ13.93113.542+0.389
TTM14.41215.843-1.431
YOY23.68118.873+4.808
5Y16.10915.030+1.079
10Y10.63921.329-10.690
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Sinco Pharms Hldg Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y1.024-1.024
5Y1.02410Y0.336+0.688
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.109-9.109
TTM-12.534-12.534
YOY-0.763-0.763
5Y1.0243.171-2.147
10Y0.3364.037-3.701
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Sinco Pharms Hldg Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Distribution industry mean).
  • A PB ratio of 0.90 means the investor is paying $0.90 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Sinco Pharms Hldg Ltd:

  • The EOD is 0.778. Based on the equity, the company is cheap. +2
  • The MRQ is 0.902. Based on the equity, the company is cheap. +2
  • The TTM is 0.938. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.778MRQ0.902-0.124
MRQ0.902TTM0.938-0.036
TTM0.938YOY7.524-6.586
TTM0.9385Y9.938-9.001
5Y9.93810Y7.276+2.662
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD0.7780.988-0.210
MRQ0.9021.119-0.217
TTM0.9381.133-0.195
YOY7.5241.303+6.221
5Y9.9381.298+8.640
10Y7.2762.044+5.232
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Sinco Pharms Hldg Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0010.001-34%0.047-98%0.010-92%0.011-93%
Book Value Per Share--0.3220.320+0%0.211+53%0.138+133%0.140+130%
Current Ratio--1.1831.235-4%1.337-11%1.040+14%0.975+21%
Debt To Asset Ratio--0.6310.603+5%0.701-10%0.796-21%0.739-15%
Debt To Equity Ratio--1.7121.530+12%2.480-31%7.709-78%5.982-71%
Dividend Per Share--0.0050.0050%-+100%0.001+375%0.001+471%
Eps--0.0050.0050%0.016-68%0.004+22%0.000+104%
Gross Profit Margin--1.0001.0000%1.0000%0.158+535%0.482+108%
Market Cap508222496.000-16%589538271.100609867177.000-3%3120486342.085-81%1223050894.783-52%1030675278.809-43%
Net Profit Margin--0.0180.006+193%0.026-32%0.021-15%-0.014+180%
Operating Margin--0.0260.006+300%0.018+42%0.021+22%0.015+70%
Operating Ratio--0.8600.440+95%0.413+108%0.535+61%0.782+10%
Pb Ratio0.778-16%0.9020.938-4%7.524-88%9.938-91%7.276-88%
Pe Ratio12.010-16%13.93114.412-3%23.681-41%16.109-14%10.639+31%
Price Per Share0.250-16%0.2900.300-3%1.535-81%0.602-52%0.507-43%
Price To Free Cash Flow Ratio----0%-0%1.024-100%0.336-100%
Price To Total Gains Ratio44.659-16%51.80553.989-4%19.242+169%34.671+49%14.410+260%
Quick Ratio--0.8560.649+32%0.551+55%0.475+80%0.433+98%
Return On Assets--0.0120.007+80%0.035-66%0.027-55%0.012-3%
Return On Equity--0.0320.017+92%0.118-72%0.194-83%0.131-75%
Total Gains Per Share--0.0060.006-7%0.047-88%0.011-48%0.012-55%
Usd Book Value--83464405.98683051148.277+0%54665121.599+53%35804223.172+133%36224267.061+130%
Usd Book Value Change Per Share--0.0000.000-34%0.006-98%0.001-92%0.001-93%
Usd Book Value Per Share--0.0410.041+0%0.027+53%0.018+133%0.018+130%
Usd Dividend Per Share--0.0010.0010%-+100%0.000+375%0.000+471%
Usd Eps--0.0010.0010%0.002-68%0.001+22%0.000+104%
Usd Free Cash Flow----0%-0%629237.713-100%-200847.3040%
Usd Market Cap64900012.739-16%75284037.21977880038.503-3%398486105.884-81%156183599.264-52%131617233.104-43%
Usd Price Per Share0.032-16%0.0370.038-3%0.196-81%0.077-52%0.065-43%
Usd Profit--2701963.5641403069.903+93%6294268.591-57%3906509.306-31%1806646.963+50%
Usd Revenue--150317975.59876932707.259+95%79526151.030+89%65017266.027+131%54435243.429+176%
Usd Total Gains Per Share--0.0010.001-7%0.006-88%0.001-48%0.002-55%
 EOD+3 -4MRQTTM+13 -12YOY+14 -155Y+19 -1310Y+20 -11

3.2. Fundamental Score

Let's check the fundamental score of Sinco Pharms Hldg Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1512.010
Price to Book Ratio (EOD)Between0-10.778
Net Profit Margin (MRQ)Greater than00.018
Operating Margin (MRQ)Greater than00.026
Quick Ratio (MRQ)Greater than10.856
Current Ratio (MRQ)Greater than11.183
Debt to Asset Ratio (MRQ)Less than10.631
Debt to Equity Ratio (MRQ)Less than11.712
Return on Equity (MRQ)Greater than0.150.032
Return on Assets (MRQ)Greater than0.050.012
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Sinco Pharms Hldg Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.480
Ma 20Greater thanMa 500.251
Ma 50Greater thanMa 1000.253
Ma 100Greater thanMa 2000.255
OpenGreater thanClose0.275
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets1,641,855
Total Liabilities1,036,560
Total Stockholder Equity605,295
 As reported
Total Liabilities 1,036,560
Total Stockholder Equity+ 605,295
Total Assets = 1,641,855

Assets

Total Assets1,641,855
Total Current Assets1,191,322
Long-term Assets450,533
Total Current Assets
Cash And Cash Equivalents 520,822
Net Receivables 341,036
Inventory 10,882
Other Current Assets 318,323
Total Current Assets  (as reported)1,191,322
Total Current Assets  (calculated)1,191,063
+/- 259
Long-term Assets
Property Plant Equipment 346,573
Goodwill 66,536
Intangible Assets 24,752
Other Assets 12,672
Long-term Assets  (as reported)450,533
Long-term Assets  (calculated)450,533
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,006,778
Long-term Liabilities29,782
Total Stockholder Equity605,295
Total Current Liabilities
Short-term Debt 200,857
Short Long Term Debt 200,857
Accounts payable 714,739
Other Current Liabilities 73,968
Total Current Liabilities  (as reported)1,006,778
Total Current Liabilities  (calculated)1,190,421
+/- 183,643
Long-term Liabilities
Long term Debt Total 7,336
Other Liabilities 22,446
Long-term Liabilities  (as reported)29,782
Long-term Liabilities  (calculated)29,782
+/-0
Total Stockholder Equity
Common Stock164
Retained Earnings 75,656
Capital Surplus 525,225
Total Stockholder Equity (as reported)605,295
Total Stockholder Equity (calculated)601,045
+/- 4,250
Other
Capital Stock164
Cash And Equivalents520,822
Cash and Short Term Investments 520,822
Common Stock Shares Outstanding 2,032,891
Liabilities and Stockholders Equity 1,641,855
Net Invested Capital 807,492
Net Tangible Assets 514,007
Net Working Capital 184,544
Property Plant and Equipment Gross 346,573



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-06-302017-12-312017-06-302016-12-312016-06-302015-12-312015-06-302014-12-312013-12-312012-12-31
> Total Assets 
122,766
376,845
441,214
539,380
464,216
852,950
787,727
934,245
819,219
698,728
611,762
0
380,947
0
764,125
0
701,436
0
1,252,053
0
1,115,319
0
1,232,766
0
1,603,354
0
1,424,333
0
1,641,855
1,641,85501,424,33301,603,35401,232,76601,115,31901,252,0530701,4360764,1250380,9470611,762698,728819,219934,245787,727852,950464,216539,380441,214376,845122,766
   > Total Current Assets 
0
0
0
0
218,963
587,173
490,071
629,482
550,633
433,090
386,085
0
157,459
554,527
554,527
500,736
500,736
1,005,727
1,005,727
870,368
870,368
968,977
968,977
1,134,415
1,134,415
1,017,406
1,017,406
1,191,322
1,191,322
1,191,3221,191,3221,017,4061,017,4061,134,4151,134,415968,977968,977870,368870,3681,005,7271,005,727500,736500,736554,527554,527157,4590386,085433,090550,633629,482490,071587,173218,9630000
       Cash And Cash Equivalents 
0
0
0
0
38,138
284,661
102,050
83,969
22,710
28,910
80,330
0
31,503
0
219,755
0
86,004
0
143,765
0
267,002
0
326,052
0
456,707
0
329,144
0
520,822
520,8220329,1440456,7070326,0520267,0020143,765086,0040219,755031,503080,33028,91022,71083,969102,050284,66138,1380000
       Short-term Investments 
0
0
0
0
0
0
111,407
109,835
1,818
3,351
16,154
0
0
0
1,990
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000001,99000016,1543,3511,818109,835111,407000000
       Net Receivables 
1,095
37,294
101,592
116,355
97,649
189,106
57,903
108,594
37,106
84,230
26,177
0
59,581
56,895
56,895
101,185
101,185
587,202
587,202
312,331
312,331
223,955
223,955
253,977
253,977
389,005
389,005
341,036
341,036
341,036341,036389,005389,005253,977253,977223,955223,955312,331312,331587,202587,202101,185101,18556,89556,89559,581026,17784,23037,106108,59457,903189,10697,649116,355101,59237,2941,095
       Inventory 
0
149,085
100,676
94,023
46,563
22,506
137,602
192,782
291,193
170,410
214,806
0
14,034
263,298
250,963
269,188
268,238
242,561
242,561
100,043
100,043
62,762
62,762
55,580
55,580
89,584
89,584
10,882
10,882
10,88210,88289,58489,58455,58055,58062,76262,762100,043100,043242,561242,561268,238269,188250,963263,29814,0340214,806170,410291,193192,782137,60222,50646,56394,023100,676149,0850
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
223,488
0
209,598
0
200,700
0
246,326
0
244,951
0
263,789
0
468,939
0
406,927
0
450,533
450,5330406,9270468,9390263,7890244,9510246,3260200,7000209,5980223,488000000000000
       Property Plant Equipment 
9,837
58,844
100,094
98,648
96,922
95,844
103,712
195,919
191,767
187,162
181,809
171,416
171,416
198,034
198,034
192,786
192,786
238,183
238,183
235,102
235,102
256,261
256,261
275,588
275,588
0
315,839
346,573
346,573
346,573346,573315,8390275,588275,588256,261256,261235,102235,102238,183238,183192,786192,786198,034198,034171,416171,416181,809187,162191,767195,919103,71295,84496,92298,648100,09458,8449,837
       Goodwill 
0
0
0
35,526
35,526
35,526
58,632
58,632
23,701
23,701
0
0
0
0
0
0
0
0
0
0
0
0
0
0
66,536
0
66,536
0
66,536
66,536066,536066,5360000000000000023,70123,70158,63258,63235,52635,52635,526000
       Intangible Assets 
0
0
0
78,427
40,378
37,834
32,454
30,104
223
168
113
0
57
0
45
0
33
0
22
0
10
0
0
0
16,500
0
15,001
0
24,752
24,752015,001016,50000010022033045057011316822330,10432,45437,83440,37878,427000
       Other Assets 
0
44,808
53,028
129,469
148,331
169,933
193,944
108,844
52,895
54,607
43,755
52,015
44,797
11,519
11,519
7,881
7,881
8,121
8,121
9,839
9,839
7,528
7,528
110,315
110,315
9,551
9,551
12,672
12,672
12,67212,6729,5519,551110,315110,3157,5287,5289,8399,8398,1218,1217,8817,88111,51911,51944,79752,01543,75554,60752,895108,844193,944169,933148,331129,46953,02844,8080
> Total Liabilities 
117,697
328,489
317,729
366,568
270,662
379,906
330,452
507,787
546,489
444,235
589,039
0
343,068
0
718,487
0
622,692
0
1,087,624
0
875,609
0
857,880
0
1,007,081
0
820,521
0
1,036,560
1,036,5600820,52101,007,0810857,8800875,60901,087,6240622,6920718,4870343,0680589,039444,235546,489507,787330,452379,906270,662366,568317,729328,489117,697
   > Total Current Liabilities 
117,697
328,489
317,729
366,568
270,662
379,906
330,452
369,405
546,489
444,235
589,039
0
342,675
522,371
522,371
576,717
576,717
990,793
990,793
703,792
703,792
725,636
725,636
847,722
847,722
790,585
790,585
1,006,778
1,006,778
1,006,7781,006,778790,585790,585847,722847,722725,636725,636703,792703,792990,793990,793576,717576,717522,371522,371342,6750589,039444,235546,489369,405330,452379,906270,662366,568317,729328,489117,697
       Short-term Debt 
0
0
0
0
0
0
111,407
109,835
409,671
3,351
145,000
0
140,000
0
1,990
0
93,984
0
77,986
0
199,022
0
207,514
0
200,000
0
180,806
0
200,857
200,8570180,8060200,0000207,5140199,022077,986093,98401,9900140,0000145,0003,351409,671109,835111,407000000
       Short Long Term Debt 
0
0
0
0
0
0
165,000
279,627
409,671
297,880
0
0
140,000
0
187,484
0
93,984
0
77,986
0
199,022
0
208,320
0
200,843
0
180,806
0
200,857
200,8570180,8060200,8430208,3200199,022077,986093,9840187,4840140,00000297,880409,671279,627165,000000000
       Accounts payable 
0
7,546
18,637
115,971
62,793
112,764
45,832
30,551
22,522
71,493
106,901
0
81,793
146,158
146,158
163,025
163,025
700,320
700,320
314,855
314,855
422,933
422,933
568,275
568,275
0
407,988
714,739
714,739
714,739714,739407,9880568,275568,275422,933422,933314,855314,855700,320700,320163,025163,025146,158146,15881,7930106,90171,49322,52230,55145,832112,76462,793115,97118,6377,5460
       Other Current Liabilities 
81,297
258,028
207,077
177,994
125,954
107,142
119,620
197,609
114,296
74,862
296,839
0
0
144,013
144,013
83,788
83,788
84,452
84,452
129,530
129,530
76,508
76,508
68,097
68,097
112,685
112,685
73,968
73,968
73,96873,968112,685112,68568,09768,09776,50876,508129,530129,53084,45284,45283,78883,788144,013144,01300296,83974,862114,296197,609119,620107,142125,954177,994207,077258,02881,297
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
393
0
196,116
0
45,975
0
96,831
0
171,817
0
132,244
0
159,359
0
29,936
0
29,782
29,782029,9360159,3590132,2440171,817096,831045,9750196,1160393000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
393
0
154
0
230
0
3,409
0
132,771
0
132,244
0
139,945
0
8,608
0
7,336
7,33608,6080139,9450132,2440132,77103,409023001540393000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
195,962
195,962
45,745
45,745
93,422
93,422
39,046
39,046
0
0
19,414
19,414
0
0
22,446
22,446
22,44622,4460019,41419,4140039,04639,04693,42293,42245,74545,745195,962195,9620000000000000
> Total Stockholder Equity
4,308
40,847
105,214
172,513
193,428
473,434
458,179
427,363
273,635
255,399
23,629
0
38,786
0
47,200
0
79,652
0
165,337
0
239,710
0
374,886
0
596,273
0
603,812
0
605,295
605,2950603,8120596,2730374,8860239,7100165,337079,652047,200038,786023,629255,399273,635427,363458,179473,434193,428172,513105,21440,8474,308
   Common Stock
0
0
0
95
95
130
130
130
130
136
136
136
136
136
136
136
136
136
136
136
136
151
151
164
164
164
164
164
164
1641641641641641641511511361361361361361361361361361361361361301301301309595000
   Retained Earnings 
16
36,555
100,922
149,621
159,250
201,598
175,398
143,878
-10,522
-59,258
-291,300
-261,564
-276,093
-253,873
-270,588
-220,767
-220,767
-135,082
-135,082
-59,324
-59,324
478
478
62,401
62,401
74,173
74,173
75,656
75,656
75,65675,65674,17374,17362,40162,401478478-59,324-59,324-135,082-135,082-220,767-220,767-270,588-253,873-276,093-261,564-291,300-59,258-10,522143,878175,398201,598159,250149,621100,92236,55516
   Capital Surplus 
0
0
0
0
0
0
0
0
258,887
289,113
289,113
0
0
0
289,113
0
289,113
0
289,113
0
288,205
0
365,774
0
525,225
0
525,225
0
525,225
525,2250525,2250525,2250365,7740288,2050289,1130289,1130289,113000289,113289,113258,88700000000
   Treasury Stock00000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
5,009
5,713
4,014
4,014
4,014
6,851
6,851
6,920
6,920
6,920
6,920
6,920
6,920
6,443
6,443
4,233
4,233
4,233
4,233
0
0
0
0
00004,2334,2334,2334,2336,4436,4436,9206,9206,9206,9206,9206,9206,8516,8514,0144,0144,0145,7135,009000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue2,271,505
Cost of Revenue-1,965,637
Gross Profit305,868305,868
 
Operating Income (+$)
Gross Profit305,868
Operating Expense-2,164,034
Operating Income117,625-1,858,166
 
Operating Expense (+$)
Research Development-
Selling General Administrative204,365
Selling And Marketing Expenses-
Operating Expense2,164,034204,365
 
Net Interest Income (+$)
Interest Income13,813
Interest Expense-18,402
Other Finance Cost-11,322
Net Interest Income-15,911
 
Pretax Income (+$)
Operating Income117,625
Net Interest Income-15,911
Other Non-Operating Income Expenses-
Income Before Tax (EBT)99,292117,625
EBIT - interestExpense = 82,822
69,462
87,864
Interest Expense18,402
Earnings Before Interest and Taxes (EBIT)101,224117,694
Earnings Before Interest and Taxes (EBITDA)124,461
 
After tax Income (+$)
Income Before Tax99,292
Tax Provision-29,830
Net Income From Continuing Ops69,46269,462
Net Income69,462
Net Income Applicable To Common Shares69,462
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-15,911
 

Technical Analysis of Sinco Pharms Hldg Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Sinco Pharms Hldg Ltd. The general trend of Sinco Pharms Hldg Ltd is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Sinco Pharms Hldg Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Sinco Pharms Hldg Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.285 < 0.295 < 0.295.

The bearish price targets are: 0.27 > 0.222 > 0.221.

Tweet this
Sinco Pharms Hldg Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Sinco Pharms Hldg Ltd. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Sinco Pharms Hldg Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Sinco Pharms Hldg Ltd. The current macd is -0.0020179.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Sinco Pharms Hldg Ltd price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Sinco Pharms Hldg Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Sinco Pharms Hldg Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Sinco Pharms Hldg Ltd Daily Moving Average Convergence/Divergence (MACD) ChartSinco Pharms Hldg Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Sinco Pharms Hldg Ltd. The current adx is 15.45.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Sinco Pharms Hldg Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Sinco Pharms Hldg Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Sinco Pharms Hldg Ltd. The current sar is 0.27945494.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Sinco Pharms Hldg Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Sinco Pharms Hldg Ltd. The current rsi is 49.48. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -3/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
Sinco Pharms Hldg Ltd Daily Relative Strength Index (RSI) ChartSinco Pharms Hldg Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Sinco Pharms Hldg Ltd. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Sinco Pharms Hldg Ltd price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Sinco Pharms Hldg Ltd Daily Stochastic Oscillator ChartSinco Pharms Hldg Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Sinco Pharms Hldg Ltd. The current cci is 11.39.

Sinco Pharms Hldg Ltd Daily Commodity Channel Index (CCI) ChartSinco Pharms Hldg Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Sinco Pharms Hldg Ltd. The current cmo is 3.28472313.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Sinco Pharms Hldg Ltd Daily Chande Momentum Oscillator (CMO) ChartSinco Pharms Hldg Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Sinco Pharms Hldg Ltd. The current willr is -49.01960784.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Sinco Pharms Hldg Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Sinco Pharms Hldg Ltd Daily Williams %R ChartSinco Pharms Hldg Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Sinco Pharms Hldg Ltd.

Sinco Pharms Hldg Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Sinco Pharms Hldg Ltd. The current atr is 0.01266505.

Sinco Pharms Hldg Ltd Daily Average True Range (ATR) ChartSinco Pharms Hldg Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Sinco Pharms Hldg Ltd. The current obv is -373,294,500.

Sinco Pharms Hldg Ltd Daily On-Balance Volume (OBV) ChartSinco Pharms Hldg Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Sinco Pharms Hldg Ltd. The current mfi is 79.46.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Sinco Pharms Hldg Ltd Daily Money Flow Index (MFI) ChartSinco Pharms Hldg Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Sinco Pharms Hldg Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-03MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-30WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-31BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-19MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-01MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.

6.3. Candlestick Patterns

Sinco Pharms Hldg Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Sinco Pharms Hldg Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.480
Ma 20Greater thanMa 500.251
Ma 50Greater thanMa 1000.253
Ma 100Greater thanMa 2000.255
OpenGreater thanClose0.275
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Sinco Pharms Hldg Ltd with someone you think should read this too:
  • Are you bullish or bearish on Sinco Pharms Hldg Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Sinco Pharms Hldg Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Sinco Pharms Hldg Ltd

I send you an email if I find something interesting about Sinco Pharms Hldg Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Sinco Pharms Hldg Ltd.

Receive notifications about Sinco Pharms Hldg Ltd in your mailbox!